Shanghai No.1 Pharmacy Co.,Ltd.

SHSE:600833 Stock Report

Market Cap: CN¥3.4b

Shanghai No.1 PharmacyLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jun Yao

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentagen/a
CEO tenure1.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.2yrs

Recent management updates

Recent updates

Investors Aren't Entirely Convinced By Shanghai No.1 Pharmacy Co.,Ltd.'s (SHSE:600833) Earnings

Nov 05
Investors Aren't Entirely Convinced By Shanghai No.1 Pharmacy Co.,Ltd.'s (SHSE:600833) Earnings

Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 19
Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 09
Shanghai No.1 PharmacyLtd's (SHSE:600833) Shareholders Have More To Worry About Than Only Soft Earnings

CEO

Jun Yao (51 yo)

1.9yrs

Tenure

CN¥1,070,300

Compensation

Mr. Jun Yao is Vice Chairman of Shanghai No.1 Pharmacy Co. Ltd. and has been its General Manager from January 05, 2023.

Board Members

NamePositionTenureCompensationOwnership
Jun Yao
Vice Chairman & GMno dataCN¥1.07mno data
Ping Wu
Director6yrsno datano data
Junpei Cheng
Independent Director6.5yrsCN¥80.00kno data
Jinbiao Li
Director6yrsno datano data
Haibo Zhang
Chairman3.8yrsCN¥1.27mno data
Li Feng
Chairman of the Board of Supervisors4.2yrsno datano data
Songlian Tang
Independent Director2.5yrsCN¥80.00kno data
Liangyu Hu
Employee Supervisor1.3yrsno datano data

4.2yrs

Average Tenure

50yo

Average Age

Experienced Board: 600833's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 15:59
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai No.1 Pharmacy Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution